PMID- 24916733
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20140612
LR  - 20140611
IS  - 1365-1501 (Print)
IS  - 1365-1501 (Linking)
VI  - 13
IP  - 2
DP  - 2009
TI  - A descriptive, open-label, long-term follow-up survey of psychotic patients 
      receiving risperidone long-acting injectable: Preliminary results.
PG  - 138-46
LID - 10.1080/13651500802570980 [doi]
AB  - Objective. To assess clinical development in patients with psychotic disorders 
      who received risperidone long-acting injectable (RLAI) in combination with 
      psychosocial interventions as part of daily clinical practice in France. Methods. 
      In this 18-month survey, patients were started on bi-monthly RLAI injections and 
      integrated in a psychosocial treatment programme. Clinical progression was 
      evaluated using the Clinical Global Impression of Severity (CGI-S) and Global 
      Assessment of Functioning (GAF) scales. In addition, data on patient 
      characteristics, adherence, RLAI dosage, concomitant medications and rates and 
      durations of hospitalization were collected. Results. Of the total of 120 
      patients included in the survey, 95 (79.2%) had previously received other 
      treatments. Non-adherence was the most frequently reported reason for changing to 
      RLAI (93 patients, 97.9%). With RLAI treatment, mean CGI-S scores improved from 
      5.6+/-0.5 at baseline to 3.6+/-1.1 at 18 months, whilst mean GAF scores increased 
      from 34.0+/-12.7 to 67+/-13.5 (both P<0.0001). Furthermore, patients had fewer and 
      shorter hospitalizations during the 18 months of RLAI treatment, compared to the 
      preceding 18 months. Conclusions. Patients with psychotic disorders benefited 
      from RLAI treatment in combination with psychosocial interventions, as shown by 
      improvements in their clinical status and functioning and reduced hospitalization 
      rates.
FAU - Viala, Annie
AU  - Viala A
AD  - Departement Medico-Psychologique du 14eme Arrondissement, Centre Hospitalier 
      Sainte-Anne, Paris, France.
FAU - Cornic, Francoise
AU  - Cornic F
FAU - Benamor, Cyrine
AU  - Benamor C
FAU - Baldacci, Chantal
AU  - Baldacci C
FAU - Cheref, Smail
AU  - Cheref S
FAU - Gauillard, Jacques
AU  - Gauillard J
FAU - Martin, Pascal
AU  - Martin P
FAU - Caroli, Francois
AU  - Caroli F
FAU - Vacheron, Marie Noelle
AU  - Vacheron MN
LA  - eng
PT  - Journal Article
PL  - England
TA  - Int J Psychiatry Clin Pract
JT  - International journal of psychiatry in clinical practice
JID - 9709509
OTO - NOTNLM
OT  - Schizophrenia
OT  - atypical antipsychotic
OT  - long-acting injectable
OT  - reintegration
OT  - risperidone
EDAT- 2009/01/01 00:00
MHDA- 2009/01/01 00:01
CRDT- 2014/06/12 06:00
PHST- 2014/06/12 06:00 [entrez]
PHST- 2009/01/01 00:00 [pubmed]
PHST- 2009/01/01 00:01 [medline]
AID - 10.1080/13651500802570980 [doi]
PST - ppublish
SO  - Int J Psychiatry Clin Pract. 2009;13(2):138-46. doi: 10.1080/13651500802570980.